Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
7
Neutral
3
Bullish
4
Bearish
17
Neutral
3
Bullish
26
Bearish
10
Neutral
0
Bullish
22
Healthcare Services
Hospital
59,431 Cr
Low Risk
163.8
60.3
1.8
14.1
890.95
519.80
Sales CAGR
Profit CAGR
ROE
ROCE

Upcoming Result Date: Nov 05, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Aster DM Quality Care Ltd (ASTERDM) is currently trading at 714.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aster DM Quality Care is an integrated healthcare platform operating hospitals, clinics, diagnostics, pharmacies and digital health services, formed by the July 1, 2026 merger of Aster DM Healthcare and Quality Care India Limited to create a unified company with about 39 hospitals, over 10,600 beds, and roughly 45,000 employees across India. The combined proforma Q1 FY27 performance was strong: consolidated revenue of INR 2,597 crore grew 20% year-on-year and EBITDA expanded 30% to INR 576 crore, lifting margins to 22.2%, driven by higher volumes, richer case mix and medical value travel growth, reflecting early operating leverage for the new combined platform. Operational momentum is broad-based: the company treated roughly two million patients in Q1 (up 13% YoY) with blended occupancy of 64% (up 510 basis points), robotics volumes up ~80% YoY and high-acuity specialties such as oncology, neurology and orthopaedics gaining traction across mature and emerging units. Aster DM Quality Care has an explicit integration and value-creation framework — a ten-point synergy wheel and a 10%–15% EBITDA uplift target on FY24 proforma EBITDA — plus a clear bed-add plan of ~4,170 beds over three to four years with 53% brownfield focus to shorten payback and improve ROCE. Balance-sheet and funding are transitional: combined net debt was INR 1,162 crore as of June 30, 2026, with Aster being net cash at INR 511 crore and Quality Care carrying INR 1,673 crore of debt, implying integration-level deleveraging and disciplined capex execution will be key for Aster DM Quality Care.
Over the past 52 weeks, Aster DM Quality Care Ltd has traded between a low of ₹519.80 and a high of ₹890.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aster DM Quality Care Ltd has a market capitalization of approximately 59,430.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aster DM Quality Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 163.80 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 59,430.63 Cr, Aster DM Quality Care Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aster DM Quality Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aster DM Quality Care Ltd is 163.80. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The earnings conference call is scheduled for Wednesday, 5 August 2026 at 6:00 PM IST.
The board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Aster DM Quality Care is the merged entity formed after Aster DM Healthcare combined with Blackstone-backed Quality Care India (QCIL), bringing four hospital brands under one listed platform.
No. The amalgamation is approved by NCLT, but it becomes effective only after the NCLT order is filed with the Registrar of Companies and other scheme conditions are met.
